Berenberg Bank Reiterates Buy Rating for Assura (LON:AGR)

Assura (LON:AGRGet Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Berenberg Bank in a report released on Tuesday, Digital Look reports. They currently have a GBX 51 ($0.67) target price on the real estate investment trust’s stock. Berenberg Bank’s target price indicates a potential upside of 21.26% from the company’s previous close.

Separately, Shore Capital reissued a “hold” rating on shares of Assura in a report on Tuesday, August 13th.

View Our Latest Stock Report on AGR

Assura Trading Up 0.5 %

Shares of LON:AGR opened at GBX 42.06 ($0.56) on Tuesday. Assura has a 12-month low of GBX 37.54 ($0.50) and a 12-month high of GBX 49.18 ($0.65). The business has a 50 day moving average of GBX 41.60 and a 200-day moving average of GBX 41.39. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.04. The stock has a market cap of £1.36 billion, a PE ratio of -4,204.00, a P/E/G ratio of 3.60 and a beta of 0.37.

Insider Transactions at Assura

In related news, insider Jonathan Murphy sold 223,534 shares of the business’s stock in a transaction dated Wednesday, July 10th. The stock was sold at an average price of GBX 42 ($0.55), for a total value of £93,884.28 ($124,021.51). 8.38% of the stock is currently owned by insiders.

Assura Company Profile

(Get Free Report)

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

Read More

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.